Search

everythinglearnresearchcommunity

for

Search:↓

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

A new system was created to classify skin changes in cancer patients based on their treatment.

Key genes linked to hair growth and cancer were identified in hairless mice.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

Mice with human skin protein K8 had more skin problems and cancer.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

The skin protects the body and is constantly renewed by stem cells; disruptions can lead to cancer.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Asiaticoside can improve wound healing after ESD by promoting tissue repair and reducing inflammation.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

A cancer patient's hair became permanently curly after treatment with nivolumab.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

New cancer treatments aim to reduce side effects and improve effectiveness.

Curcumin may improve cancer radiotherapy by making cancer cells more sensitive to radiation and protecting normal cells.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Standardized methods are needed to understand how process conditions affect extracellular vesicle protein content for skin therapy.

Tiny vesicles from stem cells could be a new treatment for healing wounds.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

FGF-7 helps hair grow by activating hair follicles and is a promising target for hair loss treatments.

Nanomaterials show promise in improving wound healing but require more research on their potential toxicity.